Professional Qualifications

Dr. Bloom started his healthcare journey as a dual trained physiotherapist and ergonomist. After working as physiotherapist for several years, he then completed his medical degree in 2011, receiving the deans letter of commendation for academic excellence in each of his clinical years. He achieved fellowship status with the Royal Australasian College of Physicians (FRACP) in 2019.

He completed his advanced training in Gastroenterology through Monash Health and Austin Health, which included invaluable experience in managing patients with advanced liver disease while training at the State Liver Transplant Unit. Additionally, he completed an additional hepatology fellowship at Eastern Health.

Clinical Expertise and Special Interests

With a personable approach, Dr. Bloom prioritises clear communication and dedicates time to his patients. Dr Bloom is an experienced consultant Gastroenterologist and Hepatologist who provides comprehensive care across all areas of Gastroenterology, including

The evaluation and management of advanced liver disease

Fibroscan

Inflammatory bowel disease (Crohn’s and ulcerative colitis)

Irritable bowel syndrome

Bowel cancer screening

Gastroesophageal reflux disease (GORD)

Gastroscopy

Colonoscopy including polypectomy and endoscopic mucosal resection (EMR)

Focus Areas

Dr. Bloom’s clinical focus extends to managing chronic liver disease and the quality endoscopy, bowel cancer screening and polypectomy. He specialises in understanding the intricate relationship between metabolic syndrome and fatty liver disease.

Accessible Healthcare

Dr Bloom is passionate about helping individuals attain their optimum health potential and welcomes enquiries from health practitioners to discuss patient needs. He is readily available for urgent appointments within a two-week timeframe and can facilitate urgent endoscopy procedures.

Research and Publications

Dr. Bloom is actively engaged in high-quality research and boasts multiple publications in the field of advanced liver disease.

1. Murphy, Elise & Roberts, Stuart & Freeman, Elliot & Stratton, Elizabeth & Davison, Scott & Levy, Miriam & Clark-Dickson, McCawley & Nguyen, Vi & Bell, Sally & Nicoll, Amanda & Dev, Anouk. (2022). Lenvatinib for the treatment of hepatocellular carcinoma – a real-world multicentre Australian cohort study. 10.21203/rs.3.rs-1714922/v1. https://www.researchgate.net/publication/362930651_Lenvatinib_for_the_treatment_of_hepatocellular_carcinoma-a_real-world_multicenter_Australian_cohort_study 
2. Robertson, Marcus & Lim, Andy & Bloom, Ashley & Chung, Will & Tsoi, Andrew & Cannan, Elise & Johnstone, Ben & Huynh, Andrew & O’halloran, Tessa & Gow, Paul & Angus, Peter & Jones, Daryl. (2021). Epidemiology and Prognostic Significance of Rapid Response System Activation in Patients Undergoing Liver Transplantation. Journal of Clinical Medicine. 10. 5680. 10.3390/jcm10235680. https://www.researchgate.net/publication/356718164_Epidemiology_and_Prognostic_Significance_of_Rapid_Response_System_Activation_in_Patients_Undergoing_Liver_Transplantation 
3. Robertson, Marcus & Lim, Andy & Johnston, Ben & Cannon, Elise & Tsoi, Andrew & Bloom, Ashley & Gow, Paul & Angus, Peter & Jones, Daryl. (2021). PO-1971 Factors associated with unplanned intensive care unit admissions following liver transplantation. Journal of Hepatology. 75. S471. https://www.researchgate.net/publication/352704607_PO-1971_Factors_associated_with_unplanned_intensive_care_unit_admissions_following_liver_transplantation 
4. Robertson, Marcus & Worland, Thomas & Bloom, Ashley. (2020). An Unusual Case of Small Bowel Obstruction. Gastroenterology. 160. 10.1053/j.gastro.2020.09.045. 
5. https://www.researchgate.net/publication/344618475_An_Unusual_Case_of_Small_Bowel_Obstruction 
6. Robertson, Marcus & Bloom, Ashley & Chung, Will & Johnstone, Ben & Cannon, Elise & Huynh, Andrew & Tsoi, Andrew & O’Halloran, Tessa & Gow, Paul & Angus, Peter & Jones, Daryl. (2020). 1357 In patients receiving liver transplantation, clinical deterioration necessitating Medical Emergency Team activation is associated with prolonged hospital length of stay and higher morbidity. Hepatology. 72. 814A. https://www.researchgate.net/publication/347986976_1357_In_patients_receiving_liver_transplantation_clinical_deterioration_necessitating_Medical_Emergency_Team_activation_is_associated_with_prolonged_hospital_length_of_stay_and_higher_morbidity 
7. Varma, Poornima & Bloom, Ashley & Patwala, Kurvi & Taylor, Kristin & De Cruz, Peter & Sparrow, Miles & Pianko, Stephen. (2020). The use of topical calcineurin inhibitors for pyoderma gangrenosum in inflammatory bowel disease: A case series. Gastroenterology, Hepatology and Endoscopy. 5. 1-3. 10.15761/GHE.1000193. https://www.researchgate.net/publication/341041482_The_use_of_topical_calcineurin_inhibitors_for_pyoderma_gangrenosum_in_inflammatory_bowel_disease_A_case_series 
8. Hui, Samuel & Chung, Will & McNamara, Lachlan & Nguyen, Paul & Bloom, Ashley & Robertson, Marcus. (2019). Sa1244 AIMS65, A risk stratification score for upper gastrointestinal bleeding, accurately predicts mortality in patients presenting with acute variceal bleeding: a prospective multicentre study. Gastrointestinal Endoscopy. 89. AB185. 10.1016/j.gie.2019.03.134. https://www.giejournal.org/article/S0016-5107(19)30325-6/fulltext 
9. Bloom, Ashley & Sarraf, Babak & Abdelmalak, Jonathan & Suen, Mathew & Britto, Kaushali & Nguyen, Kevin & Govinna, Mauli & Truong, Nadia & Lai, Mark & Long, Tony & Robertson, Marcus. (2019). Mo1238 Natural history, management and outcomes of esophageal food bolus obstruction. Gastrointestinal Endoscopy. 89. AB478. 10.1016/j.gie.2019.03.775. https://www.giejournal.org/article/S0016-5107(19)30966-6/fulltext